Winner Capital Expenditures from 2010 to 2024

300888 Stock   34.97  0.23  0.65%   
Winner Medical Co's Capital Expenditures is increasing over the years with slightly volatile fluctuation. Capital Expenditures is expected to dwindle to about 711.2 M. From 2010 to 2024 Winner Medical Co Capital Expenditures quarterly data regression line had arithmetic mean of  507,402,802 and r-squared of  0.67. View All Fundamentals
 
Capital Expenditures  
First Reported
2019-03-31
Previous Quarter
261.2 M
Current Value
175 M
Quarterly Volatility
110.8 M
 
Covid
Check Winner Medical Co financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winner Medical Co's main balance sheet or income statement drivers, such as Tax Provision of 222.6 M, Net Interest Income of 73 M or Interest Income of 140.6 M, as well as many indicators such as . Winner financial statements analysis is a perfect complement when working with Winner Medical Co Valuation or Volatility modules.
  
This module can also supplement various Winner Medical Co Technical models . Check out the analysis of Winner Medical Co Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Winner Stock

Winner Medical Co financial ratios help investors to determine whether Winner Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Winner with respect to the benefits of owning Winner Medical Co security.